The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (8.88) USD. With the latest stock price at 0.39 USD, the upside of Cytosorbents Corp based on DCF is -2377.8%.
Based on the latest price of 0.39 USD and our DCF valuation, Cytosorbents Corp (CTSO) is a sell. selling CTSO stocks now will result in a potential gain of 2377.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.3% | 6.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (24.73) - (5.63) | (8.88) |
| Upside | -6440.8% - -1544.5% | -2377.8% |